Baker Hughes
0.0 %
55.09 %
Yet to be announced
Company Overview
Baker Hughes Company provides a portfolio of technologies and services to energy and industrial value chain. It operates through four segments: Oilfield Services (OFS), Oilfield Equipment (OFE), Turbomachinery & Process Solutions (TPS), and Digital Solutions (DS) The OFS segment offers exploration, drilling, wireline, evaluation, completion, production, and intervention services. The TPS segment provides equipment and related services for mechanical-drive, compression, and power-generation applications across the oil and gas industry.
Revenue Sources
Based on Baker Hughes' financial statements and business operations, their primary revenue streams come from oilfield services, oilfield equipment, turbomachinery & process solutions, and industrial & energy technology. These activities involve providing legitimate products and services in the energy sector and do not constitute haram activities.
Reliance on Interest
| Reporting Date | Total Revenue | Total Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $6.91b | $6.03b | - | $55.0m | 0.00% | 0.91% |
| June 30, 2024 | $7.14b | $6.35b | - | $47.0m | 0.00% | 0.74% |
| March 31, 2024 | $6.42b | $5.81b | - | $41.0m | 0.00% | 0.71% |
| Dec. 31, 2023 | $6.83b | $6.23b | - | $45.0m | 0.00% | 0.72% |
Looking at the last four quarters: Interest expense as a percentage of total expenses has remained consistently below the 5% threshold, ranging from 0.7% to 0.9%. Interest income is reported as $0 across all quarters. The company's interest-related activities are not material to its core business operations.
Operational Ethics
While Baker Hughes maintains operations in various global markets, there is no evidence of material ongoing collaboration with entities involved in human rights violations. The company's business relationships appear to be primarily commercial in nature and focused on energy infrastructure development.
Login to join the discussion